Related Experiment Videos
Efficient purification of unique antibodies using peptide affinity-matrix columns.
Liselotte Brix Jensen1, Erik Riise, Leif Kofoed Nielsen
1Department of Pharmacology, The Danish University of Pharmaceutical Sciences, Jagtvej 160, DK 2100 Copenhagen, Denmark.
Journal of Immunological Methods
|January 23, 2004
Summary
Phage display identified a peptide ligand, ER6.1, that specifically binds the MK16 antibody. This peptide forms an affinity matrix for purifying MK16, crucial for multiple sclerosis research.
Area of Science:
- Biotechnology
- Immunology
- Protein Engineering
Background:
- Monoclonal antibodies like MK16 are vital tools for diagnostics and therapeutics.
- Developing specific purification methods for antibodies is essential for their efficient production and application.
- The human MHC class II molecule DR2 complexed with myelin basic protein (MBP) is a target in multiple sclerosis (MS).
Purpose of the Study:
- To identify peptide ligands with high specificity for the MK16 monoclonal antibody using phage display.
- To develop a novel affinity chromatography matrix for the purification of MK16 and its fragments.
- To investigate the fine specificity of the identified peptide ligand for the MK16 antibody.
Main Methods:
- Phage display technology was employed to screen for peptide ligands targeting the MK16 antibody.
- The selected peptide, ER6.1, was immobilized on beaded agarose to create an affinity matrix.
- The performance of the ER6.1 affinity matrix was evaluated for purifying MK16 Fab fragments and IgG from cell culture supernatants.
Main Results:
- Several peptide epitopes specifically recognizing the MK16 antibody were identified.
- The ER6.1 peptide-agarose matrix demonstrated high efficiency in purifying MK16 Fab fragments and IgG.
- The matrix showed no affinity for other antibodies and successfully separated MK16 IgG from bovine IgG in cell culture media.
- Fine specificity studies revealed that ER6.1 binds a unique epitope within the heavy chain CDR3 region of MK16, distinguishing it from variants.
Conclusions:
- Phage display is effective for identifying highly specific peptide ligands for monoclonal antibodies.
- The ER6.1 peptide-agarose matrix provides a robust and specific method for purifying MK16 antibodies and fragments.
- This purification strategy has implications for the production of therapeutic or diagnostic antibodies, particularly those targeting MS-related antigens.